New Key Statistics Module, Z-Score and F-Score
HKSE:02289 Key Ratios
Market Cap HK$ M | 1,499.04 |
Enterprise Value HK$ M | 2,501.65 |
P/E(ttm) | 26.69 |
PE Ratio without NRI | 26.80 |
Forward PE Ratio | -- |
Price/Book | 2.29 |
Price/Sales | 0.31 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.97 |
Revenue (TTM) HK$ M | 4,816.00 |
EPS (TTM) HK$ | 0.52 |
Beneish M-Score | -2.34 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 7.00 |
y-y EBITDA Growth Rate % | -29.40 |
EV-to-EBIT | 21.14 |
EV-to-EBITDA | 16.71 |
PEG | 3.83 |
Shares Outstanding M | 108.00 |
Net Margin (%) | 1.17 |
Operating Margin % | 2.61 |
Pre-tax Margin (%) | 1.53 |
Quick Ratio | 0.78 |
Current Ratio | 1.07 |
ROA % (ttm) | 1.71 |
ROE % (ttm) | 8.66 |
ROIC % (ttm) | 4.66 |
Dividend Yield % | 3.59 |
Altman Z-Score | 1.93 |
HKSE:02289 Number of Guru Trades
HKSE:02289 Volume of Guru Trades
Gurus Latest Trades with HKSE:02289
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02289 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Charmacy Pharmaceutical Co Ltd Insider Transactions
No Available Data